Home Articles  
ED Pills - Viagra, Levitra, Cialis
Categories
Archives
Articles
Interesting Facts
Tag

Tadalafil As A Treatment For Pulmonary Arterial Hypertension

Wed,26 October 2011


United Therapeutics Corporation announced that the United States Food and Drug Administration (FDA) has approved Adcirca (tadalafil) tablets for oral administration, with a recommended dose of 40 mg, as the first once-daily phosphodiesterase type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH).

Adcirca is indicated to improve exercise ability in WHO Group I PAH patients, which encompasses patients with multiple forms of PAH including etiologies such as idiopathic and familial PAH as well as PAH associated with scleroderma and congenital hear



2012 © Copyright. All Rights Reserved